Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.66
+0.74 (4.37%)
Nov 11, 2025, 4:00 PM EST - Market closed
Eton Pharmaceuticals Revenue
Eton Pharmaceuticals had revenue of $22.46M in the quarter ending September 30, 2025, with 117.54% growth. This brings the company's revenue in the last twelve months to $70.32M, up 102.77% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.
Revenue (ttm)
$70.32M
Revenue Growth
+102.77%
P/S Ratio
6.71
Revenue / Employee
$2,268,258
Employees
31
Market Cap
473.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.01M | 7.37M | 23.29% |
| Dec 31, 2023 | 31.64M | 10.39M | 48.90% |
| Dec 31, 2022 | 21.25M | -581.00K | -2.66% |
| Dec 31, 2021 | 21.83M | 21.79M | 55,879.49% |
| Dec 31, 2020 | 39.00K | -920.00K | -95.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ETON News
- 5 days ago - Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 19 days ago - Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewsWire